The Impact of Direct-to-Consumer, Video Telemedicine

直接面向消费者的视频远程医疗的影响

基本信息

项目摘要

Project Summary/Abstract Forty-six percent of employers offer insurance coverage for telemedicine services today, up from 28% in 2013. This is a significant shift from historical patterns where telemedicine care delivery was largely promoted in underserved inner city and rural areas in order to improve access to specialty care. With the expansion of the internet, faster connection speeds, improved bandwidth, and greater use of mobile devices, more patients have the means to access providers via telemedicine from their home, potentially improving access and convenience more broadly. Understanding how video telemedicine, when made widely accessible, changes the patient-provider interface is critical to understanding how to more efficiently and effectively deliver care.   Two barriers to the expansion of telemedicine on a broad basis have been 1) the lack of a telemedicine platform through which patients can access a wide range of physicians from their own home and 2) the lack of insurance coverage when provider consultation is sought. These barriers have recently been overcome by one of the largest US health insurers, which offers a direct-to-consumer, video telemedicine tool. The tool gives 19 million adults around-the-clock access to physicians via computer or mobile device, improving convenience and removing access barriers that arise from travel time, the need to leave work, or the need for child care. This form of telemedicine is distinct from disease-specific programs and from electronic telemedicine visits (“e-visits”) studied previously. Patient response to this form of direct-to-consumer, video telemedicine is not well understood. Our multi-year study will take advantage of a natural experiment provided by the insurer's introduction of the virtual visits through a direct-to-consumer telemedicine tool to study the effect of the tool on 1) patient access to care, 2) quality of care, and 3) utilization and expenditures for common conditions across alternative sources of care (retail clinics, primary care offices, emergency room). The study is innovative in its analysis of a unique natural experiment that created differential financial incentives for video telemedicine use among insured adults, its use of unique data, the size of the intervention group (19 million adult enrollees), its longitudinal design, and collaboration with a large US private insurer. Findings from this study will inform private insurer policies, state telemedicine laws and regulations, as well as Medicare and Medicaid coverage policy where coverage is geographically limited or restricted to a narrow set of services,
项目总结/摘要 46%的雇主为远程医疗服务提供保险,高于2013年的28%。 这是一个重大的转变,从历史模式中,远程医疗护理提供在很大程度上是促进 在服务不足的内城和农村地区,以改善获得专科护理的机会。在扩大 互联网、更快的连接速度、更高的带宽以及更多地使用移动的设备, 有办法从家中通过远程医疗访问提供者,这可能会改善访问, 更广泛的方便。了解视频远程医疗在广泛使用时如何改变 患者-提供者界面对于理解如何更高效和有效地提供护理至关重要。   在广泛的基础上扩展远程医疗的两个障碍是:1)缺乏远程医疗 平台,通过该平台,患者可以从自己的家中获得广泛的医生,2)缺乏 保险咨询时,请咨询供应商。这些障碍最近已被克服, 美国最大的健康保险公司之一,提供直接面向消费者的视频远程医疗工具。工具 使1900万成年人能够通过电脑或移动终端全天候接触医生, 方便和消除因旅行时间、需要离开工作岗位或需要 儿童看护。这种形式的远程医疗不同于特定疾病的计划,也不同于电子医疗。 远程医疗就诊(“电子就诊”)。患者对这种直接面向消费者的视频形式的反应 远程医疗还没有得到很好的理解。 我们的多年研究将利用保险公司推出的 通过直接面向消费者的远程医疗工具进行虚拟访问,以研究该工具对1)患者访问的影响 2)护理质量,以及3)替代资源中常见条件的利用和支出 (零售诊所、初级保健办公室、急诊室)。这项研究是创新的,它分析了一个独特的 自然实验,为被保险人使用视频远程医疗创造了不同的财政激励措施 成年人,其使用的独特数据,干预组的规模(1900万成人登记),其纵向 设计,并与美国一家大型私人保险公司合作。这项研究的结果将告知私人保险公司 政策,州远程医疗法律法规,以及医疗保险和医疗补助覆盖政策, 覆盖范围在地理上受限或限于一组狭窄的服务,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALISON Evans Cuellar其他文献

ALISON Evans Cuellar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALISON Evans Cuellar', 18)}}的其他基金

Impact of the COVID-19 Pandemic on Safety Net Performance, Disparities, and Vulnerable Children
COVID-19 大流行对安全网绩效、差异和弱势儿童的影响
  • 批准号:
    10504574
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
Impact of the COVID-19 Pandemic on Safety Net Performance, Disparities, and Vulnerable Children
COVID-19 大流行对安全网绩效、差异和弱势儿童的影响
  • 批准号:
    10705094
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
The Impact of Wellness Programs and Incentives on Preventive Services
健康计划和激励措施对预防服务的影响
  • 批准号:
    8546717
  • 财政年份:
    2012
  • 资助金额:
    $ 22.27万
  • 项目类别:
The Impact of Wellness Programs and Incentives on Preventive Services
健康计划和激励措施对预防服务的影响
  • 批准号:
    8384996
  • 财政年份:
    2012
  • 资助金额:
    $ 22.27万
  • 项目类别:
The Impact of Wellness Programs and Incentives on Preventive Services
健康计划和激励措施对预防服务的影响
  • 批准号:
    8698647
  • 财政年份:
    2012
  • 资助金额:
    $ 22.27万
  • 项目类别:
Mental Health Systems and Juvenile Justice Outcomes
心理健康系统和青少年司法成果
  • 批准号:
    6560101
  • 财政年份:
    2003
  • 资助金额:
    $ 22.27万
  • 项目类别:
Mental Health Systems and Juvenile Justice Outcomes
心理健康系统和青少年司法成果
  • 批准号:
    7334185
  • 财政年份:
    2003
  • 资助金额:
    $ 22.27万
  • 项目类别:
Mental Health Systems and Juvenile Justice Outcomes
心理健康系统和青少年司法成果
  • 批准号:
    7623760
  • 财政年份:
    2003
  • 资助金额:
    $ 22.27万
  • 项目类别:
Mental Health Systems and Juvenile Justice Outcomes
心理健康系统和青少年司法成果
  • 批准号:
    6877710
  • 财政年份:
    2003
  • 资助金额:
    $ 22.27万
  • 项目类别:
Mental Health Systems and Juvenile Justice Outcomes
心理健康系统和青少年司法成果
  • 批准号:
    6704174
  • 财政年份:
    2003
  • 资助金额:
    $ 22.27万
  • 项目类别:

相似国自然基金

基于 Direct RNA sequencing 的 RNA 甲基化介导贻贝天然免疫调控的表观遗传机制研究
  • 批准号:
    LR22D060002
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
新型滤波器综合技术-直接综合技术(Direct synthesis Technique)的研究及应用
  • 批准号:
    61671111
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目

相似海外基金

Direct to consumer marketing to engage Veterans in evidence-based psychotherapies for PTSD
直接面向消费者营销,让退伍军人参与创伤后应激障碍 (PTSD) 的循证心理治疗
  • 批准号:
    10538403
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
Direct-to-consumer genetic testing and donor-conception: support and governance in emerging digital systems
直接面向消费者的基因检测和捐赠者受孕:新兴数字系统的支持和治理
  • 批准号:
    ES/V002430/2
  • 财政年份:
    2021
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Research Grant
Direct-to-consumer genetic testing and donor-conception: support and governance in emerging digital systems
直接面向消费者的基因检测和捐赠者受孕:新兴数字系统的支持和治理
  • 批准号:
    ES/V002430/1
  • 财政年份:
    2021
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Research Grant
Linking Direct to Consumer Genomics and Electronic Health Records to Accelerate Science
直接连接消费者基因组学和电子健康记录以加速科学发展
  • 批准号:
    10195133
  • 财政年份:
    2021
  • 资助金额:
    $ 22.27万
  • 项目类别:
Understanding Use of Direct to Consumer Telemedicine for Pediatric Acute Respiratory Infections
了解直接面向消费者的远程医疗用于治疗小儿急性呼吸道感染
  • 批准号:
    10442750
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
Understanding Use of Direct to Consumer Telemedicine for Pediatric Acute Respiratory Infections
了解直接面向消费者的远程医疗用于治疗小儿急性呼吸道感染
  • 批准号:
    10202444
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
Evaluating the Risks and Benefits of the Next Generation of Direct-to-Consumer Genetic Tests
评估下一代直接面向消费者的基因测试的风险和收益
  • 批准号:
    10678974
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
Understanding Use of Direct to Consumer Telemedicine for Pediatric Acute Respiratory Infections
了解直接面向消费者的远程医疗用于治疗小儿急性呼吸道感染
  • 批准号:
    10047350
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
Restaurant Box - Direct-To-Consumer Multi-Vendor Restaurant E-commerce, Tuition & Social Platform
Restaurant Box - 直接面向消费者的多供应商餐厅电子商务,学费
  • 批准号:
    71321
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Feasibility Studies
Understanding Use of Direct to Consumer Telemedicine for Pediatric Acute Respiratory Infections
了解直接面向消费者的远程医疗用于治疗小儿急性呼吸道感染
  • 批准号:
    10649718
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了